Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

31,203 trials

NCT06712810
Recruiting
Q702 for the Treatment of Patients With Hematologic Malignancies
Phase 1 · United States · 2 sites
Registry update: 10 Oct 2025
NCT07147348
Recruiting
A First-in-human, Dose Escalation and Indication Expansion Study of BNT3212 as Monotherapy or in Combination With BNT327 in Adults With Advanced Solid Tumors
Phase 1/2 · Australia, China · 17 sites
Registry update: 15 Jun 2026
NCT07113990
Recruiting
Electroacupuncture and rTMS for Post-Stroke Motor Recovery
Not applicable · China · 3 sites
Registry update: 3 Nov 2026
NCT06188741
Recruiting
Selumetinib for the Prevention of Plexiform Neurofibroma Growth in NF Type 1
Phase 2 · United States · 15 sites
Registry update: 29 May 2026
NCT06818266
Recruiting
Efficacy and Safety of Tocilizumab for Acute Chest Syndrome Treatment in Patients With Sickle Cell Disease
Phase 3 · France · 13 sites
Registry update: 24 Jun 2026
NCT07154524
Recruiting
Immunoadsorption for Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Not applicable · Germany · 1 site
Registry update: 11 Sept 2025
NCT07062536
Recruiting
mFOLFOX/mFOLFIRI vs. mFOLFOX in Advanced or Recurrent Biliary Tract Cancer Second-line
Phase 2 · South Korea · 11 sites
Registry update: 14 Aug 2026
NCT07043400
Recruiting
A Study to Investigate Tislelizumab Administered as Subcutaneous Injection Versus Intravenous Infusion Plus Chemotherapy in Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
Phase 3 · Argentina, Austria, Brazil, China, Czechia, Spain, France, United Kingdom, Italy, Japan, South Korea, Mexico, Poland, Puerto Rico, United States · 95 sites
Registry update: 14 Oct 2026
NCT07055542
Recruiting
Creating A Risk Assessment Tool for Thunderstorm Asthma: the CARISTA Study
Not applicable · Australia · 6 sites
Registry update: 6 May 2026
NCT07084012
Recruiting
A Phase IIa Clinical Trial to Evaluate the Efficacy and Safety of Intravenous Infusion of hUC-MSCs in Patients With AIS
Phase 2 · China · 1 site
Registry update: 29 Jul 2026
NCT07262450
Recruiting
Assessement of Effectiveness of Seawater Nasal Sprays on Sinonasal Symptoms
Not applicable · France · 32 sites
Registry update: 3 Dec 2025
NCT07145190
Recruiting
SL-START - SubLingual Apomorphine Schemes of TitrAtion in Real-world Treatment
Not applicable · Germany · 12 sites
Registry update: 11 Aug 2026
NCT07085390
Recruiting
Balloon Guide Versus Conventional Guide Catheter in Stroke Thrombectomy
Not applicable · United States · 2 sites
Registry update: 22 Jul 2026
NCT07537010
Recruiting
3D1015 Injection for Patients With mCRPC
Phase 1 · China · 1 site
Registry update: 17 Apr 2026
NCT06698146
Recruiting
Colorectal Metastasis to Liver Extraction With Auxiliary Transplant and Delayed Resection
Not applicable · United States · 1 site
Registry update: 10 Jul 2026
NCT06998069
Recruiting
Head and Neck Cancer Study Project in the Geriatric Population
Phase 3 · United States · 1 site
Registry update: 20 Aug 2026
NCT07156253
Recruiting
Study of SYN818 With Olaparib for the Treatment of Locally Advanced or Metastatic Solid Tumors
Phase 1 · China · 1 site
Registry update: 5 Sept 2025
NCT07122687
Recruiting
IBI363 Combined With Chemotherapy or Pembrolizumab Combined With Chemotherapy as Neoadjuvant Therapy in Resectable Stage IB-III Non-Squamous Non-Small Cell Lung Cancer
Phase 2 · China · 1 site
Registry update: 27 Jul 2026
NCT07319039
Recruiting
Breathlessness Patterns in Patients With Cancer, COPD and Heart Failure: an fMRI Feasibility Study
Not applicable · Switzerland · 1 site
Registry update: 8 Jan 2026
NCT07169734
Recruiting
A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors
Phase 1/2 · Spain, France, Hong Kong, Italy, Netherlands, Singapore, Taiwan, United States · 41 sites
Registry update: 2 Jul 2026

Ordered by registry start date. Freshness and sponsorship never change the order.